Company profile
e-breathe smart inhaler for cannabinoids CBD and THC.
e-breathe smart inhaler for cannabinoids such as CBD and THC. Precise dose control. Full traceability. Full visibility of every use.
Financial period: 1 Apr 2024 to 31 Mar 2025
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
CS01 | Transaction MzQzODU2MTQwMWFkaXF6a2N4
Published 07 Oct 2024 09:14
Company registered at Companies House
1 Mar 2018 to 28 Feb 2019
"E-breather: Electronic inhalation device for drug delivery that improves effectiveness of delivery and patient compliance for respiratory conditions. The development of an inhalation device aims to reduce healthcare costs and enhance patient outcomes via a combination of: 1. Enhancing real-world effectiveness of drug delivery to the patient: The device s...
